Harvey's valuation reached around $8 billion after its October 2025 funding round. That figure—arrived at after a June raise of $300 million at $5 billion, then another $150 million led by Andreessen Horowitz by October—would have seemed absurd in any other moment. But this isn't 2021's frothy exuberance returning. Something else is happening.
The legal AI startup crossed $100 million in annual recurring revenue somewhere around August, CNBC reported at the time. More telling than the numbers, perhaps, is what they represent: a market finally willing to pay serious money for AI that speaks the language of contracts, knows the cadence of depositions, and understands why a particular clause matters in Delaware versus California.
Harvey isn't alone in commanding these valuations. Across legal, healthcare, and financial services, a cluster of specialized AI companies has collectively raised over $1 billion in the past year while hitting billion-dollar-plus valuations. The commonality? They're not building general-purpose assistants. They're building agents that learned the vocabulary of a specific profession—and enterprises are paying up for that fluency.
Legal AI Becomes a Crowded Billion-Dollar Market
Winston Weinberg, an ex-O'Melveny litigator, and Gabriel Pereyra, who came from Google DeepMind's research team, founded Harvey with a straightforward thesis: lawyers needed AI that understood legal work, not just language. By December 2025, the company served 337 legal clients including Paul, Weiss, KKR, and PwC. The $8 billion valuation suggests investors believe that thesis at scale.
But look around Harvey and the landscape gets interesting fast.
EvenUp, tackling personal injury law, raised $150 million in October 2025 at roughly $2 billion. Founders Rami Karabibar, Raymond Mieszaniec, and Saam Mashhad built it to handle high-volume work—demand letters, medical chronologies—that smaller firms couldn't previously afford to optimize. The company now serves more than 2,000 law firms and processes over 1,600 documents weekly, according to its own metrics. That's a lot of personal injury cases.
Canada's Spellbook took a different path entirely. In March 2026, CEO Scott Stevenson announced $40 million in debt financing from RBCx, noting the funds would "support strategic acquisitions in consolidating legal AI market." Consolidating. Not competing in, not growing within—consolidating. The company claims nearly 4,000 law firms and legal teams globally, and recently became the exclusive AI provider for the Canadian Bar Association through a two-year program. Spellbook's "Associate" agent, launched in August 2024, doesn't just assist lawyers. It's designed to orchestrate multi-step tasks the way a junior associate would.
LegalOn Technologies raised $50 million in July 2025 from Goldman Sachs Alternatives, bringing total funding to $200 million. Founders Nozomu Tsunoda and Masataka Ogasawara, working with US CEO Daniel Lewis, call their product "agentic AI for legal ops"—a phrase that's become something of an industry rallying cry, though not everyone agrees on what it means.
Meanwhile, the incumbents are moving too. Thomson Reuters paid $650 million for Casetext back in June 2023, embedding generative AI into its CoCounsel product. LexisNexis struck a data-sharing partnership with Harvey in mid-2025. This is a market where the old guard and the insurgents are both putting serious money on the table, which suggests either tremendous opportunity or an expensive mistake. Perhaps both.
Healthcare AI Hits $3.5 Billion on Patient-Facing Agents
Hippocratic AI's $126 million Series C in early November 2025 valued the company at $3.5 billion. Total funding now sits around $404 million. Founder and CEO Munjal Shah built the company on a specific bet: that healthcare needed patient-facing AI agents, not just tools to make clinicians more productive.
The distinction matters. Hippocratic now claims 50-plus health system, payer, and life sciences partners deploying over 1,000 agent use cases. Named systems include Cleveland Clinic, Northwestern Medicine, Ochsner Health, University Hospitals, WellSpan, and OhioHealth. That's a lot of institutional buy-in for technology that's essentially talking directly to patients.
Ambience Healthcare raised $243 million in July 2025, co-led by Oak HC/FT and Andreessen Horowitz, with OpenAI Startup Fund, Kleiner Perkins, and Optum Ventures participating. Founders Mike Ng and Nikhil Buduma built a platform spanning more than 100 medical specialties. Customers include Cleveland Clinic, UCSF Health, Houston Methodist, and Memorial Hermann. The company's positioning around ambient documentation, coding, and clinical decision intelligence reflects how quickly healthcare AI moved beyond simple transcription.
Abridge secured $250 million in February 2025 after crossing 100 health system deployments. Founders Shiv Rao and Zachary Lipton—a physician-scientist duo—focused initially on clinical conversation documentation. The scale of recent adoption suggests the technology has moved from pilot project to standard infrastructure, at least in some systems.
Microsoft's March 2026 case study with Intermountain Health offers concrete numbers: 2,285 clinicians using Dragon Copilot embedded in Epic saw a 27% reduction in time spent on notes per appointment. That data spans April 2024 through December 2025. Real productivity gains, if the methodology holds up to scrutiny.
Nabla raised $70 million in June 2025. Suki closed $70 million in October 2024 and has since expanded its Epic Toolbox integration through "Suki INSIDE," available in Epic Haiku and Hyperspace as of February 2025. The pattern across all these companies is identical: deep EHR integration, not standalone tools. If you're not inside Epic, you're not inside the workflow.
Finance AI Agents Tackle Audit, Banking, and Insurance
When Goldman Sachs Alternatives led Fieldguide's $75 million Series C—announced February 2, 2026—it signaled something. Institutional capital doesn't typically flow toward audit workflow automation, particularly not at that scale. Founders Jin Chang and Chris Szymansky call their product an "agentic AI OS for audit and advisory." Investor Geodesic Capital noted that 25% of Fieldguide's full-time employees are former auditors. That's not an accident. It's a staffing philosophy that reflects how much domain expertise these platforms actually require.
The company launched "Fieldguide for Financial Audit" in June 2024, extending beyond its initial SOC 2 and compliance focus. Goldman's involvement is notable mostly because financial services firms are historically conservative about workflow automation that touches client deliverables. If Goldman is comfortable funding this, others might be too.
Banking-focused Kasisto launched KAIgentic—described as an "agentic AI platform purpose-built for banking"—in August 2025. CEO Zor Gorelov's company has historically served J.P. Morgan, Westpac, Standard Chartered, and TD. These aren't institutions known for early adoption. The shift from conversational banking assistants to "agentic" workflows suggests these relationships are maturing into something more automated, whether the banks are fully ready or not.
Vic.ai introduced "VicAgents" in June 2025, positioning task-specific finance agents for enterprise accounts payable alongside new products VicPay and Vendor Portal. Founders Alexander Hagerup and Kristoffer Røil built the company around automating high-volume AP workflows. The agent launch represents a bet that enterprises are ready for more autonomy than simple invoice matching. That's a meaningful shift in trust.
Prophix announced "Prophix One Agents" for budgeting, reporting, and modeling in September 2025, with general availability starting September 27. The FP&A-focused company calls them "autonomous agents for finance." Two years ago, that would have sounded wildly ambitious. Now it reads like table stakes.
ZestyAI launched "ZORRO Discover" in July 2025, an agent for instant insights on insurance rate filings and market moves, then expanded across property and casualty lines by October. The company claims the product "improves research efficiency 20x" with citation-backed insights. In insurance underwriting and compliance research, where regulatory scrutiny runs high, that kind of efficiency claim is either transformative or a lawsuit waiting to happen. Possibly both.
The Uncomfortable Consolidation Question
Spellbook's March 2026 debt financing announcement included explicit language about "consolidating legal AI market." That's not subtle. Neither is Thomson Reuters paying $650 million for Casetext, or the data partnerships Harvey is building with LexisNexis.
The venture math only works if these companies can defend their position against both well-funded competitors and incumbent platforms with existing distribution. And incumbents have distribution that startups can only dream about.
The healthcare sector faces similar pressures, perhaps more acutely. Epic and Microsoft both have ambient documentation offerings now. Suki's Epic Toolbox integration and Ambience's work with more than 100 specialties suggest the winning strategy might be going deeper into workflows rather than broader across systems. Hippocratic's "app store" approach with 1,000-plus agent use cases could be a hedge. If agents proliferate, maybe the platform that orchestrates them wins even if individual agents become commodities.
In finance, the question is whether vertical agents become features or companies. Fieldguide's investor thesis around an "agentic AI OS" suggests a platform play. Kasisto's positioning of KAIgentic as "purpose-built for banking" implies deep specialization will create moats. Both strategies can't be right. Or perhaps they're solving for different parts of the market, and both will carve out sustainable positions. That seems optimistic.
Kore.ai, which secured a strategic growth investment from AllianceBernstein in January 2026, serves 480-plus Global 2000 customers with enterprise AI agents. That's a different game than the vertical specialists, but it's targeting the same budget conversations. CFOs evaluating Vic.ai for AP automation are also fielding pitches from horizontal platforms that promise to handle AP plus half a dozen other workflows. Someone's going to lose that argument.
From Assistant to Agent: Where Autonomy Actually Lands
The language shift from "copilot" to "agent" to "autonomous" isn't just marketing posturing.
Harvey started as a legal research assistant. Now it's orchestrating multi-step workflows across document review, contract drafting, and regulatory analysis. Spellbook's "Associate" explicitly positions an agent as handling tasks a junior lawyer would tackle. EvenUp's demand letter and medical chronology automation replaces work that previously required significant paralegal and attorney time. These aren't productivity tools. They're workforce replacements, or at least workforce augmentation at a scale that changes headcount planning.
In healthcare, ambient documentation was the entry point—transcribing conversations doctors were already having. Safe enough. But Ambience's positioning around coding and clinical decision intelligence, or Hippocratic's patient-facing agents handling appointment scheduling and care navigation, represents workflows where the AI initiates action rather than documenting it. The Microsoft-Intermountain case study's 27% reduction in time per note matters, certainly. But it's still a productivity gain on existing work. When agents start triaging patients or recommending next steps, the value proposition shifts from efficiency to capacity expansion. That's when things get interesting, and potentially risky.
Finance might be the most revealing vertical, because the workflows are more structured and the margin for error is lower. Autonomous agents for budgeting and reporting, as Prophix describes them, can't just be 95% accurate. They need to match human precision on compliance and audit requirements while being faster. ZestyAI's insurance research agent claiming 20x efficiency improvements only works if underwriters trust the citations and feel comfortable signing off. Fieldguide's audit platform only scales if partners will sign off on AI-generated work papers. That's not a technology question. It's a professional liability question.
The companies hitting billion-dollar-plus valuations are the ones convincing enterprises that we've crossed that threshold—that the AI is reliable enough, accurate enough, and auditable enough to trust with high-stakes work.
Whether that confidence is justified or wildly premature is perhaps the $15 billion question hanging over this entire market. We'll know soon enough. The enterprises writing these checks will either prove the skeptics wrong or provide case studies for the next market correction. Maybe a little of both.
